Ameliora Wealth Management’s Twist Bioscience TWST Stock Holding History

Ameliora Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,800	Closed	-$140K	–	235
2025 Q2	$140K	Hold	3,800	–	–	0.05%	119
2025 Q1	$149K	Hold	3,800	–	–	0.06%	116
2024 Q4	$177K	Hold	3,800	–	–	0.07%	106
2024 Q3	$172K	Hold	3,800	–	–	0.07%	87
2024 Q2	$187K	Hold	3,800	–	–	0.09%	88
2024 Q1	$130K	Hold	3,800	–	–	0.06%	103
2023 Q4	$140K	Hold	3,800	–	–	0.07%	86
2023 Q3	$77K	Hold	3,800	–	–	0.05%	108
2023 Q2	$77.7K	Hold	3,800	–	–	0.05%	110
2023 Q1	$57.3K	Hold	3,800	–	–	0.03%	125
2022 Q4	$90.5K	Hold	3,800	–	–	0.05%	110
2022 Q3	$115K	Buy	+3,800	New	+$161K	0.06%	95

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Ameliora Wealth Management's TWST Position: Q3 2025 in Review

Ameliora Wealth Management sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 3,800 shares — an estimated $140K sold.

Ameliora Wealth Management first reported a position in TWST in Q3 2022 and held it in 12 quarters. The position peaked at $187K in Q2 2024. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

Ameliora Wealth Management reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
Ameliora Wealth Management sold 3,800 Twist Bioscience shares in Q3 2025, an estimated $140K.
Ameliora Wealth Management first reported a position in Twist Bioscience in Q3 2022 and held it in 12 quarters.
Ameliora Wealth Management's Twist Bioscience position peaked at $187K in Q2 2024.
238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Ameliora Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.